|  RBHS

Institute for Infectious & Inflammatory Diseases (i3D)

Call to Action

Please signup to stay tuned with our most recent updates, news, events information about i³D

News view all

In August 2022, Dr. Aimee M. Beaulieu, Assistant Professor and Chancellor Scholar, Center for Immunity and Inflammation and Department of Microbiology, Biochemistry, & Molecular Genetics, and colleagues published a study in The Proceedings of the National Academy of Sciences demonstrating that the cytokine, IL-33, is a key regulator of pregnancy progression and type 2 immune responses at the maternal-fetal interface in mice. Read More

In September 2022, Jianya Peng and Chandler Sy from Dr. Mark Siracusa’s lab published a paper in PNAS showing an important role for monocytes in maintaining central nervous system homeostasis following an intestinal parasite challenge. Read More




Upcoming Events view all

2023 i3D Symposium – May 16 & 17, 2023

Host-Microbe interactions in health and disease

Doubletree by Hilton at Newark Penn Station ~ 1048 Raymond Blvd. ~ Newark, NJ

Co-chairs: Nick Bessman and Darin Wiesner


Registration                   Directions

Text Box:


The human immune system has evolved to face the challenge of pathogens and environmental insults while simultaneously supporting a healthy community of microbes. The host-microbe interplay impacts every facet of health and disease. Recent technological breakthroughs have facilitated new paradigms of host-microbe interactions and immune development that underlie infection, autoimmunity, inflammatory disease, and cancer. This area of research shows tremendous untapped potential for promoting health and developing new therapeutic strategies to treat chronic disease. The goal of this symposium is to bring together internationally-renowned leaders with diverse perspectives to share recent discoveries in this field, with the goal of supporting collaborative efforts to promote health and treat disease.

Text Box:











Breaking the Poverty-Disease Cycle

Dysfunction of the immune system is increasingly recognized as contributing to a broad spectrum of infectious and noninfectious diseases. The specific focus of our new institute provides a unique opportunity to build an innovative and significant program of biomedical research excellence for Newark and the State of New Jersey. It provides the opportunity to develop innovative perspectives and insights for the development of new treatments and diagnostics that can be rapidly translated to the clinic.